pl
en
Country
pl
Language
en

Ibrutinib in treatment of patients with chronic lymphocyte leukemia

Speciality: Hematology
Language : Polski
Broadcast type : Live conference
Duration : 00:08:01
Date: December 20, 2017

New Drug Program - Ibrutinib in the treatment of patients with chronic lymphocytic leukemia allows to change the perspective on high-risk CLL therapy.

Other in: Hematology